False
Drug Discovery

Filter by
- Interviews
- Cell & Gene
- Bioprocessing
- Drug Delivery
- Drug Discovery
- Development & Clinical
- Formulation
- Facilities & Equipment
- Outsourcing
- Packaging
- Regulation & Standards
- Small Molecules
- Supply Chain
- Industry News
- Research News
- Sitting Down With
- Innovation Awards
- Business & Trends
- Technology & Manufacturing
- Biopharma
- Future of Pharma
- Latest
- Blogs
New Weight-Loss Drug Aims for Results Without Harsh GI Effects
July 2, 2025
A new dual agonist GLP-1 is showing weight loss without gastrointestinal side effects and appetite suppression. We speak with the company to learn more.
3 min read
The Biosimulation Generation
July 1, 2025
Since the FDA announced plans to phase out mandatory animal testing, in silico drug discovery and development platforms are emerging. Welcome to the age of biosimulation.
6 min read
Targeting the Untouchables: Covalent Peptides That Target Elusive Transcription Factors
June 27, 2025
Researchers have developed a new way to create covalent peptide inhibitors of transcription factors – proteins once considered “undruggable.”
8 min read
Nut-Based Pharmaceuticals: From Food Waste to Functional Medicine
By Rob Coker
June 26, 2025
A look at how nut-derived pharmaceutical ingredients can deliver a sustainable, natural supply of peptides and more.
2 min read
Gene Therapy Meets Nanotechnology
By Stephanie Vine
June 24, 2025
Researchers explore how ocular gene delivery strategies for diabetic retinopathy could be improved using nanotechnology.
3 min read
Gene Therapies for Newborns
By Stephanie Vine
June 4, 2025
Work from the lab of Luigi Naldini identifies postnatal window for in vivo gene editing, without the need for conditioning or transplantation
2 min read
How Amgen Delivered a New Rare Disease Therapy
June 2, 2025
We speak with experts from Amgen and Henry Ford Health about the development and approval of Uplizna for IgG4-related disease.
9 min read
$400,000 Prize Honors Pioneers of CAR T-Cell Therapy
By Stephanie Vine
May 28, 2025
“The development of CAR T-cell technology is a defining moment in the history of biomedicine – one of the all-time amazing transformative breakthroughs.”
3 min read
Eli Lilly and Purdue Expand Partnership with $250 Million Investment
By Rob Coker
May 19, 2025
Eli Lilly and Purdue University strengthen their ongoing drug discovery collaboration with further initiatives.
2 min read
False
Recommended
False